1-10 of 10
Tami D John
Close
Sort by
Journal Articles

Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study

Elizabeth Stenger, Tami D. John, Deepak Chellapandian, Rikin Shah, Scott Gillespie, Yijin Xiang, Katie Liu, Monica Bhatia, Gregory M.T. Guilcher, Jennifer Jaroscak, Kimberly A. Kasow, Jennifer Krajewski, Alexander I. Ngwube, Hemalatha G. Rangarajan, John T. Horan, Lakshmanan Krishnamurti, Shalini Shenoy, Allistair Abraham
Journal: Blood
Blood (2023) 142 (Supplement 1): 4955.
https://doi.org/10.1182/blood-2023-188514
Published: 2023
Journal Articles

Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study

Tami D. John, Deepak Chellapandian, Rikin Shah, Scott Gillespie, Katie Liu, Yijin Xiang, Monica Bhatia, Sonali Chaudhury, Michael J. Eckrich, Gregory M.T. Guilcher, Jennifer Jaroscak, Kimberly A. Kasow, Jennifer Krajewski, Alexander I. Ngwube, Timothy S Olson, Hemalatha G. Rangarajan, John T. Horan, Lakshmanan Krishnamurti, Shalini Shenoy, Allistair Abraham, Elizabeth Stenger
Journal: Blood
Blood (2023) 142 (Supplement 1): 4904.
https://doi.org/10.1182/blood-2023-182532
Published: 2023
Journal Articles

Red Cell Rheology and Blood Viscosity in Pediatric Individuals Having Received Allogenic Hematopoietic Stem Cell Transplantation or Ex Vivo Autologous Gene Therapy for Sickle Cell Disease

Ashwin P. Patel, Celeste K. Kanne, Elizabeth O Stenger, Tami D. John, Vivien A. Sheehan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1076.
https://doi.org/10.1182/blood-2023-188045
Published: 2023
Journal Articles

Targeting of CD25+ Activated T Cells in Gvhd-Associated Marrow Suppression and Cytopenias

Tami D. John, Laura Valine, Giulia Barbarito, Hye-Sook Kwon, Sally Arai, Beth Martin-Kool, Radhika Kumari, Judith Shizuru, Jean S. Oak, Robertson Parkman, Alice Bertaina, Kenneth I. Weinberg
Journal: Blood
Blood (2023) 142 (Supplement 1): 7033.
https://doi.org/10.1182/blood-2023-190968
Published: 2023
Journal Articles

Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)

Anirudh Veludhandi, Tami D John, Nitya Bakshi, Staci D. Arnold, Monica Bhatia, Peter A. Lane, Lillian Meacham, Kirshma Khemani, Sonali Chaudhury, Festus Olusola Olowoselu, Kimberly A. Kasow, Matthew Hsieh, Allistair Abraham, Gregory M.T. Guilcher, Lakshmanan Krishnamurti
Journal: Blood
Blood (2021) 138 (Supplement 1): 3030.
https://doi.org/10.1182/blood-2021-152383
Published: 2021
Journal Articles

Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders

Olive S. Eckstein, MD, Nitya Gulati, MBBS, Lisa Forbes, MD, Erin Peckham-Gregory, PhD MPH, Nmazuo Wudo Ozuah, MBBS, M. Cecilia Poli, MD, PhD, Tiphanie Vogel, Emily M Mace, PhD, Jordan S Orange, MD PhD, Jason Caldwell, D.O., Stephen Jolles, Fracesco Saettini, Hey J Chong, Asbjørg Stray-Pedersen, Helen E. Heslop, MD DSc, Kala Kamdar, MD, Robert A. Krance, MD, Swati Naik, MBBS, Tami D John, MD, Rayne H. Rouce, MD, Donna Muzny, Shalini Jhangiani, Richard Gibbs, Zeynep Coban-Akdemir, James Lupski, Kenneth L. McClain, MD PhD, Carl E. Allen, MD PhD, Ivan Chinn
Journal: Blood
Blood (2019) 134 (Supplement_1): 83.
https://doi.org/10.1182/blood-2019-131884
Published: 2019
Journal Articles

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era

Erin E Doherty, MD, Michele Redell, MD, Ghadir Sasa, MD, Khaled Yassine, MD, Tami D John, MD, John Craddock, Mengfen Wu, MS, Tao Wang, PhD, Caridad A. Martinez, MD, Robert A. Krance, MD, Swati Naik, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2056.
https://doi.org/10.1182/blood-2019-131131
Published: 2019
Journal Articles

Rheological Assessments of Sickle Cell Patients Post Allogeneic Hematopoietic Cell Transplant

Tami D John, MD, Madeleine Lu, BS, Celeste K. Kanne, BA, Minke A.E. Rab, MD, Richard van Wijk, PhD, Sergey S. Shevkoplyas, PhD, Vivien A. Sheehan, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 996.
https://doi.org/10.1182/blood-2019-128946
Published: 2019
Journal Articles

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

David K. Buchbinder, MD MSHS, Ruta Brazauskas, PhD, Khalid Bo-Subait, Karen K. Ballen, MD, Theresa E. Hahn, PhD, Tami D John, MD, Susan K Parsons, MD MRP, Shahrukh K. Hashmi, MD MPH, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 2260.
https://doi.org/10.1182/blood-2018-99-116531
Published: 2018
Journal Articles

Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment

Tami D John, MD, Khaled Yassine, MD, Swati Naik, MBBS, Ghadir Sasa, MD, Bilal Omer, MD, Caridad A. Martinez, MD, Priti Tewari, MD, Robert A. Krance, MD, Kathryn S Leung, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2086.
https://doi.org/10.1182/blood-2018-99-113856
Published: 2018